Sheldon Freeberg is a Cardiology physician. OpenAlex indexes 8 publications with 430 citations (h-index 6).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
703 S Fleishel Ave
Suite 4000
Tyler, TX 757012015
Telephone
903-606-7000Provider last certified this registry record 2 Jun 2023.
Industry payments
22 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Medtronic, Inc.Program year202572 payments
- Abbott LaboratoriesProgram year202513 payments
- Shockwave Medical, IncProgram year202511 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83%Statin17.7%Atorvastatin Calcium50%Rosuvastatin Calcium40%Pravastatin Sodium6%Simvastatin5%Part D≥130 patientsBeta blocker17.4%Carvedilol40%Metoprolol Succinate35%Metoprolol Tartrate25%Part D≥109 patients+ 14 more classes in this area
Metabolism & gastrointestinal
8.5%SGLT2 inhibitor3.5%Jardiance74%Farxiga27%Part D≥36 patientsPotassium supplement3.2%Potassium Chloride100%Part D≥54 patients+ 1 more class in this area
Blood & clotting
8.4%P2Y12 inhibitor5.8%Clopidogrel86%Prasugrel Hcl14%Part D≥86 patientsFactor Xa inhibitor2.7%Eliquis80%Xarelto20%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Comparison of primary percutaneous coronary intervention in patients with<scp>ST</scp>‐elevation myocardial infarction during and prior to availability of an in‐house<scp>STEMI</scp>system: Early experience and intermediate outcomes of the<scp>HARRT</scp>program for achieving routine<scp>D</scp>2<scp>B</scp>times <60 minutes
Catheterization and Cardiovascular Interventions
2014 - Efficacy of Mechanical Circulatory Support Devices for Termination of Drug – Refractory Sustained Ventricular Tachycardia
Journal of Clinical & Experimental Cardiology
2011 - Case Series: Tension Pneumothorax Complicating Narrow-Bore Enteral Feeding Tube Placement
Journal of Intensive Care Medicine
2010 - Aspirin augments 15-epi-lipoxin A4 production by lipopolysaccharide, but blocks the pioglitazone and atorvastatin induction of 15-epi-lipoxin A4 in the rat heart
Prostaglandins & Other Lipid Mediators
2006
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”